Radio Frequency Technology: to heat, sense, detect and connect. Offering solutions to societal challenges you probably have not thought of yet.

The Netherlands, world leading country in RF Technology
Radio Frequency (RF) technology knowledge is significantly strong developed in the
Netherlands. No less than thirty Dutch companies are highly specialized in RF technology
and its applications.
The Netherlands is home to many great inventions in RF technology. Bluetooth and WIFI,
worldwide embraced and indispensable innovations, have their origins and crucial
development in the Netherlands. And, with the knowledge and expertise of Dutch RF
engineers, so much more can become possible with RF technology. Welcome to the world of
RF solutions!

RF offers solutions you probably have not thought of yet
RF is already widely used and the number of Radio Frequency (wireless) applications will
explode in the coming years. Wireless and contactless connected, will be the new standard.
Think of IoT applications, medical imaging such as MRI or, autonomous driving, and adaptive
cruise control.
But there is more. RF offers excellent solutions for the necessary transition from fossil fuels
to green energy. RF is clean and sustainable. In addition, it is ultra-accurate, hygienic, and
highly controllable. For sensing, detecting, and heating RF is the most efficient technique that
we know of. It can and should be used in more and different kinds of industries.

A few examples
• Energy: RF is clean, sustainable, fast, and controllable. In all cases where we use gas
nowadays, RF is an excellent replacement.
• Food: Heating becomes more hygienic (contactless), more accurate, and faster with RF
technology.
• Health: RF technology offers more accurate sensing and imaging, more fidelity, and more
detail. Thanks to these features, severe diseases can be detected at an earlier
stage.
• Logistics: RF offers opportunities for better capacity utilization in the available space through
precise positioning capabilities and more secure movement. Think of moving
vehicles and loading and unloading in large complex distribution centers.
• Mobility: Extremely accurate RF sensing makes it possible to apply more autonomous traffic
flows thanks to Car-to-car interaction, adaptive cruise control, and the interaction
between cars and traffic instruments such as traffic lights and signaling signs. This
contributes to a better flow of vehicles and therefore directly to better living
conditions in urban areas.

And that’s really just the tip of the iceberg. RF developments can also contribute to data
transfer, security and safety, climate, transport etc. RF Technology can contribute to your
business as well.

Do you feel the need to use RF Technology for sustainable, more efficient solutions to
the challenges in your business? The RF Knowledge Lab can put you in contact with
the right RF specialist. Contact us and let’s find out together.

RF Knowledge Lab
The RF Knowledge lab is a collaboration of companies, universities, and research
organizations. All with specific RF expertise. This group of professionals, brought together by
High Tech NL, has joined forces to explore the possibilities and opportunities for RF
solutions. Both in the Netherlands and abroad. This promising initiative has the warm
support of local and provincial governments.
The RF Knowledge Lab is the best entry point to new RF innovations and solutions. By joining
the RF Knowledge Lab you become part of the future of RF Technology.

Can your company contribute to this collaboration? We want to get in touch! Contact
us and be part of the ecosystem!

Victor Haze
Project manager High Tech NL cluster Holland Semiconductors
M +31 (0)6 8399 9327
E contact@rfkl.nl

How to attract venture capital investment for your innovation?

This workshop focuses on innovative startups/entrepreneurs that might not yet be ready to apply for series A capital but are determined to get there in the next few years and wish to think ahead.

Great ideas are important but not enough to create a sustainable businesses. Building a company needs a lot of effort from the right talents. But sooner or later external money is also needed to attract the right people and grow the business. Often starting with friends, family and fools, then angel investment and at one moment in time also serious investments by venture capital. While building the company it is important to be aware of the criteria that the different investors use in choosing investments and to be able to work towards meeting them.

In this workshop Thijs Cohen Tervaert, investor and Director at Inkef Capital, will explain the role of venture capital, the criteria used in selecting the right investments and how even early on in your startup you can prepare for these. For some participants of the workshop it is possible to give short pitches and get feedback from Thijs (send an email to Briskr when you are interested to pitch yourself).

INKEF Capital was established in 2010 to finance and support starting entrepreneurs and their spectacular technology ventures. INKEF is short for Investing in the Knowledge Economy of the Future. With ABP/APG as a founding partner and cornerstone investor, they are able to focus all their passion and expertise on two broad technology sectors: Healthcare and ICT/New Media/FinTech.

This workshop is free of charge. We welcome new contacts, so feel free to share this invite with your network!

Good to know

We organize this workshop in a live setting and finish off with drinks & bites. This workshop is free of charge and facilitated in English. Please register upfront!

Location: Noviotech Campus, building M, Transistorweg 5, Nijmegen

Pitch to Win

Practical tools to help you build your winning pitch.

David Beckett Bio
David Beckett is an international pitch coach, who has trained over 1400 Startups to win over €340Million in investment, working with Accelerators such as Startupbootcamp, ThinkAccelerate and Rockstart. He’s also trained more than 20.000 people at companies such as ING, PwC, Netflix, Tata and Toyota, in 31 countries. David is the creator of The Pitch Canvas©, and the author of the book Pitch To Win.

Workshop description
Following the great success of last year’s workshop, David will once again share the steps and tools to prepare for your winning pitch in this practical, fast-paced & very active workshop.

You’ll get guidance on how to build your storyline creatively, how to make your message understandable and memorable, and how to open and close powerfully. All steps are practiced in short and fun exercises.

Afterwards, you’ll receive a selection of materials and access to an App that will help you deliver your winning pitch, handshake pitch and/or elevator pitch!

Location
Noviotech Campus, building M, Transistorweg 5, Nijmegen.

Good to know
The workshop is facilitated in English and is free of charge and organised together with Mercator Launch.

Enzyre uses investments to save thousands on healthcare

Enzyre uses investments to save thousands on healthcare
According to Guido Maertens, co-founder and CEO of Enzyre, money is key to success in the world of biotech and life science. “In this world, you really have to believe in your own plans and products, otherwise it gets very tough. But the potential for our product is worth the effort since the treatment of haemophilia is extremely expensive.” With the completion of this Series A round, Enzyre has secured funding to further develop its first product for haemophilia and platform technology.

Right now, it’s all about making their prototype robust for Enzyre. “We want to move towards clinical validation testing. As a research tool, we don’t want to get stuck. The ultimate goal is to help patients at home. That’s why we have to step up the quality!”

What will Enzyre help patients at home with? The company focuses on patients with haemophilia, a chronic blood disease. “These people do not have enough active factor-8 protein, so the blood doesn’t clot sufficiently. Quite simply, a small bleed can already have extreme consequences for these people.” Patients in the Netherlands receive proper, often prophylactic treatment. “They inject medication every week. But as a patient, you also want to know how much medication is left in your blood. That’s where we come in.”

Monitoring for peace of mind

Enzyre is currently developing the EnzyPad, a tool that allows patients to monitor their medication levels. So how does that work? “It starts with taking a blood sample. Fortunately, this can be done painlessly with a blood sampling device. You put that sample on our EnzyCard, our test card. We mix the blood with a number of chemicals. This causes a reaction, producing light. You can measure light in the form of photons. Simply put: if there are too few photons, it’s time for more medication.”

This simple monitoring provides peace of mind for patients, according to Guido. “Patients now know exactly how well the medication is working. It reassures them. They know they’re protected, should something happen. It also means that people can lead a more active life because fear doesn’t hold a grip on them.” There are also major benefits for the healthcare system. “Treatment for haemophiliacs costs around €250,000 a year. So any saving quickly yields a profit.”

Long- and short-term

In the short term, Enzyre is going to use the money it raised to go from a prototype to a product. This also includes the realization of a pilot product line. But there is also the long term. “We don’t just want to focus on haemophilia. We want to become a leading company in the world of blood clotting. We probably need a partnership for that, with a diagnostic company, for example. We are very good at research and development, but we could use some help with sales or distribution.”

Enzyre is already working with many companies in the region. “The Noviotech Campus has brought us a lot in terms of networking. We develop our hardware in collaboration with Sencio and EPR Partner. And our first sensors came from NXP!”

Thousands of potential savings

Guido is also very happy about the partnership with Takeda. “They are a very big pharmaceutical company, with an awful lot of content knowledge. For a company like Enzyre, a partnership like that is rather unique, but we’re happy to be working together. We couldn’t have closed this investment round without Takeda.” The successful round of investment brings patients one step closer to leaving their fears behind. This way Enzyre continues to use its network on and off campus to lower the impact of haemophilia on patients’ lives. As medication is costly, their product has the potential to lower healthcare costs by thousands of euros per patient.

This article is published by Noviotech Campus.

Protinhi Therapeutics semi-finalist iin ZELSIF

Protinhi Therapeutics, a company located at Noviotech Campus Nijmegen, is nominated as a semi-finalist in ZELSIF this year, and will be presenting their journey to European and Chinese medical experts and investors during the event on the 16th of December.

The ZELSIF 2022 International Top 15 winners will receive the “ZELSIF 2022” award, which goes along with the privileged opportunity to introduce their solutions to Chinese healthcare experts, investors, and industrials through an online pitch presentation. In the next two weeks, the semi-finalist companies will compete for the top 7 final winners who will receive further awards in cash.

Protinhi Therapeutics is an early-stage biotech company aiming to combat (emerging) viral infectious diseases with a high unmet medical need via protease inhibition. With their proprietary technology platform, they are actively developing novel antiviral drugs that inhibit proteases and block viral replication. The aim for easy-to-administer drugs able to treat in epidemic and pandemic situations.

https://set.kuleuven.be/lhtc/News

Posted by Karina Garcia, Kadans Science Partner.

HOW DO WE REMEMBER (BETTER)?

Every single day, all day long, we make extensive use of our memory. At what time was that meeting again? Did we close the fridge at home properly this morning? A failing memory can trouble our everyday tasks, while a great memory can greatly ease our lives, for example in memorizing a list or learning a new language. There are many things that can influence memory development during our upbringing, but also in adulthood its performance might change over time. How does the brain handle this on a neuronal level? Can anything be done to boost memory performance? And why is it that we don’t have memories from before the age of four?

You might still have a memory of this Science Cafe being moved due to illness. On a second chance, Monday January 16^th, memory experts Freyja Ólafsdóttir and Boris Konrad of the Radboud University will be welcomed in the Shamrock to introduce us to the wonders of memory. Ólafsdóttir takes a fundamental approach, implementing a range of techniques that allow the investigation of single neuron activity and their embedding in neuronal network patterns. In this way, she investigates the development of spatial and episodic memory in rodents. Konrad, on the other hand, studies the neuronal principles underlying memory enhancement in humans and the advantages of different memory strategies. Moreover, he investigates the effects of modern technology on our brain. The inspiring musical presence of Punch! will make this a night to remember (with ease)!

scientists /8pm Freyja Ólafsdóttir (RU) and Boris Konrad (RU)

music /7.30pm Punch!

moderator Cees Leijenhorst

time Monday January 16th 2023, 7.30/8 – 10 pm
venue The Shamrock, Smetiusstraat 17 in Nijmegen

admission free admission (no reservation)

language English

info www.sciencecafenijmegen.nl

Unieke financieringstafel biedt alternatief voor innovatieve ondernemers

Banken slaan handen ineen met Oost NL en The Economic Board Arnhem-Nijmegen

REGIO ARNHEM-NIJMEGEN: Rabobank, ING en ABN-AMRO hebben samen met Oost NL en The Economic Board Arnhem-Nijmegen een financieringstafel voor het MKB opgericht. Innovatieve ondernemers met een goed businessplan, die eerder een financieringsvraag afgewezen zagen worden, kunnen bij de financieringstafel aankloppen voor een manier om hun bedrijfsplan alsnog te financieren. De financieringstafel verwacht op deze manier vele ondernemers per jaar te kunnen ondersteunen.

De financieringstafel zet in op zowel innovatie als financiering en is bedoeld om innovaties die de regio hard nodig heeft, een grotere kans van slagen te bieden. Oost NL verzorgt de intake en brengt de casussen in bij de financieringstafel. Jan van Dellen, directeur The Economic Board Arnhem-Nijmegen, is bestuurlijk voorzitter van de tafel.

Regio heeft innovaties hard nodig

Rabobank constateerde in een rapport uit 2021, dat gebleken is dat ondernemers moeite hebben om innovatieve ideeën gefinancierd te krijgen. De financieringstafel gaat daarom in januari 2023 direct van start met de behandeling van de eerste ingebrachte casussen. Jan van Dellen kan niet wachten tot het zover is: “We staan al maanden te popelen om onze ondernemers te gaan helpen. Je moet je voorstellen dat als jij een goed idee hebt, voor een startup of jouw jonge bedrijf wilt uitbreiden, dat niks zo vervelend is als in de wachtkamer zitten omdat je niet weet waar je terecht kunt met je financieringsvraagstuk. Onze regio heeft innovatieve ondernemers keihard nodig om de vraagstukken van de toekomst op te lossen. Hoe brengen we de energierekening in de wijken omlaag? Welke toepassingen in de zorg helpen om de volksgezondheid in onze regio op peil te houden tegen lagere kosten? Met de financieringstafel gaan we ondernemers helpen om de oplossingen van morgen naar de markt te brengen.”

Grootbanken slaan handen ineen

Uniek aan de financieringstafel is dat de grootbanken Rabobank, ING en ABN-AMRO zich samen inzetten om een alternatief te creëren. Casussen worden door Oost NL verzameld en daarna anoniem ingebracht en op inhoud besproken, waarna er gekeken wordt welke bank de best aansluitende financieringspartner is. Aanvragen die niet passen binnen de kaders die de banken hanteren, worden gekoppeld aan alternatieve financiers, zoals investeringsfondsen, business angels of crowdfunding. Jan van Dellen: “Het komt voor dat een ondernemer nog niet in staat is om te voldoen aan de eisen die aan financiering gesteld worden. In zo’n geval kan de financieringstafel ook helpen een coachingstraject op te zetten, subsidiemogelijkheden in kaart helpen brengen of doorverwijzen naar een partner die gespecialiseerd is in begeleiding van opkomende ondernemers. Uitgangspunt is dat we een zetje in de rug willen geven op de best passende manier.”

Innovaties om te overleven

De voortdurende veranderingen in kennis, producten en diensten, werkwijzen, gedrag, welvaart, maatschappelijke verhoudingen, kortom, de voortdurende veranderingen in de wereld vereisen een continue aandacht van ondernemers voor die veranderingen, dus aandacht voor innovatie. Dit is noodzakelijk om te overleven, juist in deze zeer moeilijke tijden voor het MKB. Daarom is de vraag om financiering veel méér dan vraag om werkkapitaal voor de dagelijkse bedrijfsvoering. Jan van Dellen: “Zonder investeringen in mensen, nieuwe processen, methoden en producten en ICT kan geen bedrijf succesvol blijven.”

De financieringstafel bestaat uit vertegenwoordigers van de Rabobank, ING, ABN-AMRO, Oost NL en The Economic Board Arnhem-Nijmegen. Het bestuurlijk overleg wordt voorgezeten door The Economic Board. Met deze publiek private samenwerking willen we in de gezamenlijke samenwerking impact maken om innovaties te versnellen en zo te kunnen bijdragen aan maatschappelijke vraagstukken.

Health Valley Event 2023

Het Health Valley Event (HVE) op 30 maart 2023 in Pathé Nijmegen is hét meest vooruitstrevende zorginnovatie event van Nederland en tevens dé ontmoetingsplaats voor iedereen die zich bezighoudt met innovaties, business en wetenschap in de Life Sciences & Health sector. Afgelopen jaren trok het event jaarlijks zo’n duizend bezoekers, live op locatie, online of in een hybride opzet.

Transition in Healthcare

De gezondheidszorg is in beweging en dat merken we allemaal. Er liggen kansen die we vandaag moeten grijpen om de zorg van morgen beter te maken. Op het Health Valley Event 2023 zoomen we dieper in op betaalbare en toegankelijke zorg van vandaag en morgen, ondersteund door technologische innovaties. Zo kijken we naar de noodzaak van preventie, naar de kansen voor de juiste zorg op de juiste plek en naar de mogelijkheden voor waardegedreven zorg. En we gaan aan de slag met de uitdagingen op de arbeidsmarkt en de betaalbaarheid van de zorg. Kortom, een vol en gevarieerd programma op 30 maart! In één dag ben je bijgepraat over de laatste trends en ontwikkelingen, bieden we je unieke netwerkkansen om samen verder te bouwen en ga je aan het einde van de dag naar huis met nieuwe inspiratie. Join the transition!

Meer informatie en kaarten vind je hier.

Reimbursement for your healthcare innovation

Brilliant business models in healthcare

Who is your client?
As an entrepreneur in healthcare you may have a great product to improve quality and efficiency in healthcare but still have a hard time selling it. The decision to use new technologies is divided between healthcare organisations and professionals, insurance companies and sometimes even patients. Often costs and returns are in different hands making renumeration hard. And in turn that might cause a lack of interest from investors.

Renumeration
This workshop will focus on renumeration in Health care systems in general and specifically on the Dutch Healthcare system. It will give insight in the way the Healthcare system is organized and what you should know if you want to get renumeration for your innovation!

What’s in it for me?
Jeroen will also show a lot of examples of the sort of brilliant business models which are needed to improve healthcare and realize the quadruple aim: better health, nicer treatment, happier healthcare workers and reduced cost. And then it’s time to apply the information to your own business case! There will be ample time to discuss, improve and refine your individual case with Jeroen and the other attendees.

About Jeroen
Jeroen Kemperman is sr. Manager Strategy & Business Development at Achmea/Zilveren Kruis and writer of several books on business models. He does this from his background in industrial engineering as well as from his practical perspective of working in healthcare. For his books he has researched working business models in the complex world of world-wide healthcare.

Live event
We aim to organize this workshop in a live setting (large room, small group) and will take all necessary RIVM/national guidelines into account. If a physical workshop is not possible, we will convert to an online session.

Book & Registration
In preparation of the workshop (and for future reference) we will send you the recommended book ‘Brilliant business models in Healthcare’ from Jeroen Kemperman, Jeroen Geelhoed & Jennifer op ’t Hoog (or in Dutch: ‘Briljante Businessmodellen in de Zorg’).

We charge a small fee of €50,- to cover the expenses of this workshop (book & postage). We are a not for profit organisation, so any revenues will be reinvested in future workshops & events.

We welcome new people, so feel free to share this invite with your network!

Schrijf je in voor de Nationale Zorginnovatieprijs 2023!

Ben jij een ondernemer uit Gelderland of Overijssel? Heb jij een innovatief zorgproduct ontwikkeld dat al succesvol is getest en geïmplementeerd bij de eindgebruiker? En wil je jouw markt vergroten of het product verder verbeteren? Schrijf je dan nu in voor de achtste editie van de Nationale Zorginnovatieprijs 2023! Deelnemers maken kans op de vakjuryprijs ter waarde van €10.000,- of de publieksprijs van €5000,-. Schrijf je voor 4 januari 2023 in!

Maak kans op €10.000!

Zorginnovatie.nl heeft het doel om innovaties in zorg en welzijn te versnellen. Ondernemingen die hun innovatie al uitgewerkt, getest en gelanceerd hebben, kunnen vaak een duwtje in de rug gebruiken om hun onderneming echt tot een succes te maken. Daarom wordt op 30 maart 2023 de Nationale Zorginnovatieprijs uitgereikt; een prijs speciaal voor de meest innovatieve onderneming in de opschalingsfase. De uitreiking van de prijs vindt plaats op het Health Valley Event.

Deelnemers maken kans op:

Een geldbedrag ter waarde van €10.000,- (vakjuryprijs) of €5.000,- (publieksprijs);
Finalisten krijgen gratis toegang en een eigen stand op het Health Valley Event;
Professionele begeleiding bij de verdere ontwikkeling van je innovatie;
Toegang tot het netwerk van Zorginnovatie.nl.

Belangrijke data

4 januari 2023: sluiting aanmeldingen om 12:00 uur
6 februari – 3 maart 2023: regionale voorrondes tijdens de Slimme Zorgestafette
20 maart 2023: stemronde voor publieksprijs wordt geopend op Zorginnovatie.nl
27 maart 2023: stemronde voor publieksprijs wordt gesloten
30 maart 2023: uitreiking Nationale Zorginnovatieprijs 2023 op het Health Valley Event

Vakjury en publieksjury

Na de bekendmaking van de finalisten begin maart, zal een vakjury zich buigen over de genomineerden en hen inhoudelijk beoordelen. De leden van de vakjury worden later bekend gemaakt. Daarnaast kan elke finalist campagne voeren om zoveel mogelijk stemmen van het publiek voor zich te winnen. De innovatie met de meeste stemmen (met uitzondering van de winnaar van de vakjuryprijs) wint vervolgens de publieksprijs.

Schrijf je nu in voor de Nationale Zorginnovatieprijs 2023!

De Nationale Zorginnovatieprijs is dé kans voor scale-ups om de ontwikkeling van hun innovatie te versnellen! Ga voor meer informatie over de Nationale Zorginnovatieprijs 2023 en het inschrijfformulier naar www.zorginnovatie.nl/nationale-zorginnovatieprijs.